Understand what your gut health results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
Estimating how well your microbes build butyrate
The butyrate capacity test analyzes your stool to estimate how effectively your gut microbes can produce butyrate, one of the most important short-chain fatty acids in the colon. Many labs use DNA sequencing on stool to quantify the genes that drive butyrate synthesis, such as the pathways that convert dietary fibers into butyrate. This can be done with shotgun metagenomics, which reads a broad set of microbial genes and functions, or with 16S-based methods that infer likely producers at the genus level. Some versions pair gene or taxa data with direct short-chain fatty acid measurement using laboratory chemistry methods like gas chromatography to quantify butyrate present in the sample. Results reflect your current gut ecosystem and recent diet, not a permanent trait.
Why this matters is simple biology. Butyrate is the preferred fuel for colon cells, supports tight junctions that keep the gut barrier intact, and modulates immune balance in the intestinal lining. It influences motility, visceral sensitivity, and mucus production, and it signals through the gut–brain and gut–metabolic axes. Research links adequate butyrate production to lower intestinal inflammation, better barrier integrity, and healthier metabolic tone, though individual responses vary and more research is needed. In short, butyrate capacity is a functional snapshot of how your microbiome turns fiber into a health-protective molecule.
Why a capacity read beats a one-time measurement
Connecting the dots from biology to daily life, this test helps you see whether your microbial assembly line for butyrate is humming along or sputtering. Low capacity often tracks with depleted populations of classic butyrate producers like Faecalibacterium, Roseburia, and Eubacterium rectale, or with a low abundance of the enzyme systems that complete butyrate synthesis. That pattern can coexist with gas, irregularity, food sensitivity, or a gut that feels easily irritated. It can also appear after antibiotics, during highly restrictive or ultra low fiber eating, or under chronic stress. On the other hand, robust capacity usually reflects a diverse microbiome that efficiently ferments fibers and resistant starches from foods like beans, oats, and slightly green bananas into short-chain fatty acids that feed and soothe the colon lining.
Zooming out, butyrate production is a pillar of systemic health. It bolsters the gut barrier, influences immune tone, and helps shape metabolic signals that touch blood sugar regulation and satiety hormones. Several studies associate higher butyrate availability with improved markers of inflammation and metabolic resilience over time, although the field is still evolving. Regular testing can show how your choices are landing in real life. For example, increasing fiber variety or easing a high-stress period may shift your butyrate pathways and the taxa that run them. The aim is not perfection but pattern recognition. Knowing your baseline and your trajectory helps you and your clinician personalize strategies for digestion, comfort, and long-term health while respecting that context, symptoms, and other labs all matter.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Reading capacity vs. direct butyrate measurement
Your report typically shows either the relative abundance of genes involved in butyrate synthesis or the presence of key butyrate-producing microbes, often compared to a reference population. Some reports also provide a measured stool butyrate level. In general, a balanced profile features higher diversity and a healthy representation of producers like Faecalibacterium and Roseburia, along with strong signals from butyrate pathway genes. That pattern suggests efficient fermentation of fiber into short-chain fatty acids, a well-fed gut lining, and lower inflammatory signaling. Optimal ranges vary across individuals due to genetics, geography, and diet, so interpretation focuses on trends and context rather than a single “perfect” number.
If your results suggest low capacity, you may see fewer butyrate-producing taxa, weaker pathway signals, or a profile that skews toward species often seen with inflammation. This is not a diagnosis. It is a functional clue that your microbiome may be under-fueled or out of balance and could respond to nutrition strategies or, if symptoms persist, a medical evaluation. Keep in mind that stool butyrate can be tricky to interpret because most butyrate is absorbed by the colon before it reaches the toilet, and values can be influenced by recent meals, transit time, and sample handling. Method matters too. Shotgun metagenomics captures functional genes directly, while 16S approaches infer function from who is present. Medications, supplements, and recent illnesses can also shift the picture. The most useful insights come from pairing this test with your history and other biomarkers and then watching how the pattern changes over time.
Frequently Asked Questions
References
- Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L (2016). Bifidobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut. *Frontiers in Microbiology*, *7*, 979. https://doi.org/10.3389/fmicb.2016.00979
- Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. *Cell*, *165*(6), 1332-1345. https://doi.org/10.1016/j.cell.2016.05.041
- Durazzi F, Sala C, Castellani G, Manfreda G, Remondini D, De Cesare A (2021). Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. *Scientific Reports*, *11*, 3030. https://doi.org/10.1038/s41598-021-82726-y
- Lynch SV, Pedersen O (2016). The human intestinal microbiome in health and disease. *The New England Journal of Medicine*, *375*(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
- Porcari S, Mullish BH, Asnicar F, Ng SC, Zhao L, Hansen R, O'Toole PW, Raes J, Hold G, Putignani L, Gasbarrini A, Segata N, Cammarota G (2025). International consensus statement on microbiome testing in clinical practice. *The Lancet Gastroenterology & Hepatology*, *10*(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X














